323 related articles for article (PubMed ID: 25273699)
1. Elevated autocrine EDIL3 protects hepatocellular carcinoma from anoikis through RGD-mediated integrin activation.
Feng MX; Ma MZ; Fu Y; Li J; Wang T; Xue F; Zhang JJ; Qin WX; Gu JR; Zhang ZG; Xia Q
Mol Cancer; 2014 Oct; 13():226. PubMed ID: 25273699
[TBL] [Abstract][Full Text] [Related]
2. An integrin beta4-EGFR unit promotes hepatocellular carcinoma lung metastases by enhancing anchorage independence through activation of FAK-AKT pathway.
Leng C; Zhang ZG; Chen WX; Luo HP; Song J; Dong W; Zhu XR; Chen XP; Liang HF; Zhang BX
Cancer Lett; 2016 Jun; 376(1):188-96. PubMed ID: 26996299
[TBL] [Abstract][Full Text] [Related]
3. Overexpressed EDIL3 predicts poor prognosis and promotes anchorage-independent tumor growth in human pancreatic cancer.
Jiang SH; Wang Y; Yang JY; Li J; Feng MX; Wang YH; Yang XM; He P; Tian GA; Zhang XX; Li Q; Cao XY; Huo YM; Yang MW; Fu XL; Li J; Liu DJ; Dai M; Wen SY; Gu JR; Hong J; Hua R; Zhang ZG; Sun YW
Oncotarget; 2016 Jan; 7(4):4226-40. PubMed ID: 26735172
[TBL] [Abstract][Full Text] [Related]
4. Effect of fibulin-5 on adhesion, migration and invasion of hepatocellular carcinoma cells via an integrin-dependent mechanism.
Tang JC; Liu JH; Liu XL; Liang X; Cai XJ
World J Gastroenterol; 2015 Oct; 21(39):11127-40. PubMed ID: 26494967
[TBL] [Abstract][Full Text] [Related]
5. Peroxiredoxin 4 suppresses anoikis and augments growth and metastasis of hepatocellular carcinoma cells through the β-catenin/ID2 pathway.
Wang W; Shen XB; Huang DB; Jia W; Liu WB; He YF
Cell Oncol (Dordr); 2019 Dec; 42(6):769-781. PubMed ID: 31256347
[TBL] [Abstract][Full Text] [Related]
6. The 14-3-3σ protein promotes HCC anoikis resistance by inhibiting EGFR degradation and thereby activating the EGFR-dependent ERK1/2 signaling pathway.
Song J; Liu Y; Liu F; Zhang L; Li G; Yuan C; Yu C; Lu X; Liu Q; Chen X; Liang H; Ding Z; Zhang B
Theranostics; 2021; 11(3):996-1015. PubMed ID: 33391517
[TBL] [Abstract][Full Text] [Related]
7. High expression level of EDIL3 in HCC predicts poor prognosis of HCC patients.
Sun JC; Liang XT; Pan K; Wang H; Zhao JJ; Li JJ; Ma HQ; Chen YB; Xia JC
World J Gastroenterol; 2010 Sep; 16(36):4611-5. PubMed ID: 20857535
[TBL] [Abstract][Full Text] [Related]
8. EDIL3 is a novel regulator of epithelial-mesenchymal transition controlling early recurrence of hepatocellular carcinoma.
Xia H; Chen J; Shi M; Gao H; Sekar K; Seshachalam VP; Ooi LL; Hui KM
J Hepatol; 2015 Oct; 63(4):863-73. PubMed ID: 25980764
[TBL] [Abstract][Full Text] [Related]
9. FAM134B induces tumorigenesis and epithelial-to-mesenchymal transition via Akt signaling in hepatocellular carcinoma.
Zhang ZQ; Chen J; Huang WQ; Ning D; Liu QM; Wang C; Zhang L; Ren L; Chu L; Liang HF; Fan HN; Zhang BX; Chen XP
Mol Oncol; 2019 Apr; 13(4):792-810. PubMed ID: 30556279
[TBL] [Abstract][Full Text] [Related]
10. HDGF-related protein-3 is required for anchorage-independent survival and chemoresistance in hepatocellular carcinomas.
Xiao Q; Qu K; Wang C; Kong Y; Liu C; Jiang D; Saiyin H; Jia F; Ni C; Chen T; Zhang Y; Zhang P; Qin W; Sun Q; Wang H; Yi Q; Liu J; Huang H; Yu L
Gut; 2013 Mar; 62(3):440-51. PubMed ID: 22490522
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-26a promotes anoikis in human hepatocellular carcinoma cells by targeting alpha5 integrin.
Zhang X; Cheng SL; Bian K; Wang L; Zhang X; Yan B; Jia LT; Zhao J; Gammoh N; Yang AG; Zhang R
Oncotarget; 2015 Feb; 6(4):2277-89. PubMed ID: 25537511
[TBL] [Abstract][Full Text] [Related]
12. Sulfatide epigenetically regulates miR-223 and promotes the migration of human hepatocellular carcinoma cells.
Dong YW; Wang R; Cai QQ; Qi B; Wu W; Zhang YH; Wu XZ
J Hepatol; 2014 Apr; 60(4):792-801. PubMed ID: 24333181
[TBL] [Abstract][Full Text] [Related]
13. Identification of prognostic biomarkers associated with the occurrence of portal vein tumor thrombus in hepatocellular carcinoma.
Lin T; Lin Z; Mai P; Zhang E; Peng L
Aging (Albany NY); 2021 Apr; 13(8):11786-11807. PubMed ID: 33878734
[TBL] [Abstract][Full Text] [Related]
14. LncRNA AY promotes hepatocellular carcinoma metastasis by stimulating
Kang CL; Qi B; Cai QQ; Fu LS; Yang Y; Tang C; Zhu P; Chen QW; Pan J; Chen MH; Wu XZ
Theranostics; 2019; 9(15):4421-4436. PubMed ID: 31285770
[No Abstract] [Full Text] [Related]
15. LncRNA DBH-AS1 facilitates the tumorigenesis of hepatocellular carcinoma by targeting miR-138 via FAK/Src/ERK pathway.
Bao J; Chen X; Hou Y; Kang G; Li Q; Xu Y
Biomed Pharmacother; 2018 Nov; 107():824-833. PubMed ID: 30142544
[TBL] [Abstract][Full Text] [Related]
16. DNA methylation-mediated silencing of matricellular protein dermatopontin promotes hepatocellular carcinoma metastasis by α3β1 integrin-Rho GTPase signaling.
Fu Y; Feng MX; Yu J; Ma MZ; Liu XJ; Li J; Yang XM; Wang YH; Zhang YL; Ao JP; Xue F; Qin W; Gu J; Xia Q; Zhang ZG
Oncotarget; 2014 Aug; 5(16):6701-15. PubMed ID: 25149533
[TBL] [Abstract][Full Text] [Related]
17. CCDC178 promotes hepatocellular carcinoma metastasis through modulation of anoikis.
Hu X; Zhao Y; Wei L; Zhu B; Song D; Wang J; Yu L; Wu J
Oncogene; 2017 Jul; 36(28):4047-4059. PubMed ID: 28319061
[TBL] [Abstract][Full Text] [Related]
18. Astrocyte elevated gene 1 (AEG-1) promotes anoikis resistance and metastasis by inducing autophagy in hepatocellular carcinoma.
Zhu HD; Liu L; Deng H; Li ZB; Sheng JQ; He XX; Tian DA; Li PY
J Cell Physiol; 2020 Jun; 235(6):5084-5095. PubMed ID: 31691973
[TBL] [Abstract][Full Text] [Related]
19. Exosome-mediated secretion of LOXL4 promotes hepatocellular carcinoma cell invasion and metastasis.
Li R; Wang Y; Zhang X; Feng M; Ma J; Li J; Yang X; Fang F; Xia Q; Zhang Z; Shang M; Jiang S
Mol Cancer; 2019 Jan; 18(1):18. PubMed ID: 30704479
[TBL] [Abstract][Full Text] [Related]
20. ZNF32 induces anoikis resistance through maintaining redox homeostasis and activating Src/FAK signaling in hepatocellular carcinoma.
Li K; Zhao G; Ao J; Gong D; Zhang J; Chen Y; Li J; Huang L; Xiang R; Hu J; Lin P; Wei Y
Cancer Lett; 2019 Feb; 442():271-278. PubMed ID: 30439540
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]